English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
ASH 2009: Novel agents for multiple myeloma
Share :
ASH 2009
3 Dec 2011
Please rate this video
The information in this video was of interest to me
The information in this video is likely to improve my clinical practice or research
I would recommend this video to my colleagues
Published:
1 Mar 2010
Views:
10110
Rating:
Save
Rate video
Dr Shaji Kumar - Hematology, Mayo Clinic, Rochester, USA
Dr Shaji Kumar discusses the improvement in treatment of multiple myeloma with new novel agents, specifically bortezomib and lenalidomide.
Categories:
Haematology oncology
Related Videos
Patient-derived iPSCs faithfully represent the genetic diversity and cellular...
Dr Eirini Papapetrou - Icahn School of Medicine at Mount Sinai, New York, USA
28 Apr 2023
Hemopathy burden at National Cancer Center
Dr Kao Vannarith - Calmette Hospital, Phnom Penh, Cambodia
25 Apr 2023
ALLO-316 demonstrates encouraging anti-tumour activity for patients with...
Dr Samer Srour - The University of Texas MD Anderson Cancer Center, Houston, USA
20 Apr 2023
Choosing Wisely in hemato-medical oncology
Dr Omar Abdihamid - Garissa Cancer Centre, Garissa, Kenya
28 Mar 2023
Haemopathy burden in the National Cancer Center of Cambodia
Dr Vannarith Kao - Calmette Hospital, Phnom Penh, Cambodia
20 Mar 2023
Choosing wisely in multiple myeloma
Dr Bishesh Poudyal - Civil Service Hospital, Kathmandu, Nepal
20 Mar 2023
Multiple myeloma
Dr Bishesh Poudyal - Civil Service Hospital, Kathmandu, Nepal
16 Mar 2023
Choosing Wisely in multiple myeloma
Dr Hamisa Iddy - Ocean Road Cancer Institute, Dar es Salaam, Tanzania
8 Mar 2023
ZUMA-7: Axi-cel is superior to standard of care across common prognostic...
Dr Fred Locke - Moffitt Cancer Center, Tampa, USA
23 Dec 2022
More from
e
cancer